Skip to main content
OpenTrials

Clinical trial condition

Gonadal Disorders

Explore clinical trials studying Gonadal Disorders. Study availability and eligibility vary by location and protocol.

4,168 public trials 784 recruiting studies
Refine in advanced search Browse all conditions

Gonadal Disorders trial results

Completed

Open-Label Study of Setmelanotide in Hypothalamic Obesity

NCT04725240

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disorders of Sex Development, +11 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • University of Florida Gainesville, Florida, United States
  • Children's Minnesota Saint Paul, Minnesota, United States
  • Vanderbilt University School of Medicine Nashville, Tennessee, United States
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors

NCT00104676

Conditions
Carcinoma, Embryonal, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations
  • M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States
  • Centre Paul Papin Angers, France
  • Institut Bergonie Bordeaux, France
  • C.H.U. de Brest Brest, France
View all 24 locations
View Trial Details
Completed

Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer

NCT00753545

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Research Site Berkeley, California, United States
  • Research Site San Francisco, California, United States
  • Research Site West Hollywood, California, United States
  • Research Site Sunrise, Florida, United States
View all 107 locations
View Trial Details
Completed

Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer

NCT04406623

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • City of Hope Duarte, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Stephenson Cancer Center at Oklahoma University Oklahoma City, Oklahoma, United States
View Trial Details

Related conditions